Diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and Haemophilus influenzae type b conjugate vaccine (Sanofi)

吸附无细胞百白破灭活脊髓灰质炎乙型肝炎（重组）和b型流感嗜血杆菌（结合）联合疫苗（赛诺菲）

Report date: 2026/05/26 20:00:28

Base Information

Drug NameDiphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and Haemophilus influenzae type b conjugate vaccine (Sanofi)
Drug Alias NameDTaP-IPV-HB-PRP-T白喉，破伤风，百日咳，乙型肝炎，脊髓灰质炎和B型流感嗜血杆菌结合疫苗（Sanofi）DTaP-IPV-Hep B-PRP-Tdiphtheria (D), tetanus (T), pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliomyelitis (inactivated) (IPV) and Haemophilus influenzae type b (Hib) conjugate vaccine (adsorbed)Hib-DTaP-Hepatitis-B-Poliovirus vaccine (Sanofi) +[10] 
ClassificationVaccines > Vaccine type > Combination vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis BPoliomyelitisTetanus +[7] 
Global Approved IndicationsHepatitis BPoliomyelitisTetanus +[6] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2013/04/17
Country/TerritoryMexicoSouth AfricaIndia +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSanofi Pasteur
China Registration ClassN/A

Develop Information

Active CompaniesSanofi PasteurSanofi Pasteur EuropeSanofi Winthrop Industrie SA
Inactive CompaniesN/A
Active IndicationsHepatitis BPoliomyelitisTetanus +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeJ07CA09
Related LinksN/A